Integration of irinotecan and cisplatin with early concurrent conventional radiotherapy for limited-disease SCLC (LD-SCLC)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Integration of irinotecan and cisplatin with early concurrent conventional radiotherapy for limited-disease SCLC (LD-SCLC)

Published:2009-06 Issue:3 Volume:14 Page:230-236
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Abdelwahab Sherif,Abdulla Hatem,Azmy Ali,Abdelfatah Ahmed,Abdel-Aziz Hany,Margerges Maha,Riad Atef,Sharma Vinay,Dwedar Ibrahim

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-008-0842-7.pdf

Reference32 articles.

1. Sekine I, Nishiwaki Y, Noda K, et al. (2003) Randomized phase II study of cisplatin, irinotecan and etoposide combinations administered weekly or every 4 weeks for extensive small-cell lung cancer (JCOG9902-DI). Ann Oncol 14:709–714

2. Murray N (1997) Treatment of small cell lung cancer: the state of the art. Lung Cancer 17:S75–S89

3. Mountain CF (1987) Staging of lung cancer: the new international system. Lung Cancer 3:4–11

4. Rosti G, Bevilacqua G, Bidoli P, et al. (2006) Small cell lung cancer. Ann Oncol 17(Suppl 2):ii5–ii10

5. Kurup A, Hanna NH (2004) Treatment of small cell lung cancer. Crit Rev Oncol Hematol 52:117–126

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation analysis of serum cystatin C, uric acid and lactate dehydrogenase levels before chemotherapy on the prognosis of small‑cell lung cancer;Oncology Letters;2020-11-25

2. Systemic therapy for limited stage small cell lung carcinoma;Journal of Thoracic Disease;2020-10

3. A systematic review of survival following anti-cancer treatment for small cell lung cancer;Lung Cancer;2020-03

4. Interaction of Chemotherapy and Radiation;Clinical Radiation Oncology;2016

5. Phase II Study of Induction Cisplatin and Irinotecan Followed by Concurrent Carboplatin, Etoposide, and Thoracic Radiotherapy for Limited-Stage Small-Cell Lung Cancer, CALGB 30206;Journal of Thoracic Oncology;2013-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3